Genalyte Inc. Announces CE Mark for Maverick Detection System
Published: Mar 26, 2013
Genalyte's Maverick Detection System uses a silicon chip containing arrays of photonic ring sensors that simultaneously analyze multiple antibodies and other proteins from a single small sample. The one-step workflow of the Maverick multiplex system can deliver accurate results in as little as 15 minutes from small volume samples of many types. The Maverick platform has a large dynamic range and excellent sensitivity with outstanding reproducibility.
"The Maverick System and our growing family of multiplex assays have generated a great deal of interest in Europe, so this CE mark designation and the appointment of our first European distributors are especially timely," said Martin Gleeson, PhD, Chief Scientific Officer of Genalyte. "We plan to launch several new multiplex assays in the coming months and also expect to announce additional distributor agreements as we build a distribution network to reach pharmaceutical, biotechnology and academic researchers around the globe."
The Maverick Detection System and its ENA 4, ENA 6 and ANA 14 Assay Kits are commercially available. Assay kits for SLE, Sjogren's syndrome and type I diabetes research are available under Genalyte's Technology Access Program. Additionally, Genalyte offers researchers a Custom Spotting Service that loads proteins supplied by customers, such as antibodies, peptides, biomarkers, cytokines and antigens, onto standard-format Genalyte chips that are ready to be run on the Maverick System.
For more information, visit www.genalyte.com. Maverick assays are currently available for research use only.
Founded in 2007, Genalyte, Inc. is commercializing the Maverick detection platform based on the company's revolutionary Microring Sensor Technology a new approach to multiplexing that leverages advances in silicon photonics to reduce or eliminate sample preparation, provide scalable multiplexing for both proteins and nucleic acids from a single small sample, and achieve excellent sensitivity and up to eight logs of dynamic range.
About Bucher Biotec
Bucher Biotec AG is a privately held Swiss distributor representing some of the most advanced US and European manufacturers of highly innovative life science research instrumentation, associated reagents and consumables. The company's customer base includes the pharmaceutical, biotechnology and agricultural and food-related industries, along with life science research institutions, clinical and environmental labs and university hospitals. The Bucher team focuses on understanding customers' needs in order to propose optimal solutions to demanding research tasks and to help accelerate scientific exploration. For more information, visit www.bucher.ch/en/home.html
Mokascience's team of experienced and technology/application-driven people provide innovative and reliable products with demonstrated added-value to Life Science researchers in the pharmaceutical and biotechnology industries and at academic labs and biobanks in France. The company works closely with its suppliers to provide the best support to customers, and the quality of its pre- and post-sales service is a top priority. For more information, visit www.mokascience.fr
About KRD Molecular Technologies
KRD is a private distribution company focused on the provision of high quality products and services to life science organizations in the Czech Republic, Slovakia and Hungary. Its clients include major scientific institutions, universities, hospitals and pharmaceutical and biomedical companies. Its portfolio includes laboratory equipment, specialized workstations and instruments, molecular biology reagents, laboratory consumables and software. KRD is committed to service quality and has been awarded an ISO 9001:2011 certificate. For more information visit www.krd.cz
Martin Gleeson, PhD
BLL Partners, LLC
Chief Scientific Officer
+1 858 750-4470
+1 212 584-2276
SOURCE Genalyte, Inc.